Ritlecitinib: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

18 May 2024

  • curprev 16:0216:02, 18 May 2024‎ Rithish Nimmagadda talk contribs‎ 10,128 bytes +22‎ No edit summary
  • curprev 16:0116:01, 18 May 2024‎ Rithish Nimmagadda talk contribs‎ 10,106 bytes +10,106‎ Created page with "{{DrugProjectFormSinglePage |authorTag={{VSRN}} |genericName=ritlecitinib |aOrAn=a |drugClass=janus kinase 3 (JAK3) inhibitor and also an inhibitor of the tyrosine kinase |indicationType=treatment |indication=severe alopecia areata in adults and adolescents 12 years of age and older |hasBlackBoxWarning=Yes |adverseReactions=Most common adverse reactions (incidence ≥1%) are headache, diarrhea, acne, rash, urticaria, folliculitis, pyrexia, atopic dermatitis, dizziness, i..."
Retrieved from "https://www.wikidoc.org/index.php/Ritlecitinib"